Report Detail

Other Global Molecular Point of Care (POC) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4517820
  • |
  • 06 March, 2023
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Molecular Point of Care (POC) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Molecular Point of Care (POC) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Molecular Point of Care (POC) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Molecular Point of Care (POC) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Molecular Point of Care (POC) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Molecular Point of Care (POC) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Point of Care (POC)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Point of Care (POC) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc. and Biocartis NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Molecular Point of Care (POC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Respiratory
Other
Market segment by Application
Clinical
Research
Market segment by players, this report covers
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health, inc.
Biocartis NV
bioMérieux SA
Cepheid
Credo Bioscience
Curetis NV
DiaSorin S.p.A
GenMark Diagnostics
Greiner Bio-One GmbH
Meridian Bioscience, Inc.
Mesa Biotech, Inc.
QIAGEN NV
QuantuMDx Group
Quidel Corporation
Roche
Sekisui Diagnostics LLC
T2 Biosystems
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Point of Care (POC) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Point of Care (POC), with revenue, gross margin and global market share of Molecular Point of Care (POC) from 2018 to 2023.
Chapter 3, the Molecular Point of Care (POC) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Point of Care (POC) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Point of Care (POC).
Chapter 13, to describe Molecular Point of Care (POC) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Molecular Point of Care (POC)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Molecular Point of Care (POC) by Type
    • 1.3.1 Overview: Global Molecular Point of Care (POC) Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Molecular Point of Care (POC) Consumption Value Market Share by Type in 2022
    • 1.3.3 Respiratory
    • 1.3.4 Other
  • 1.4 Global Molecular Point of Care (POC) Market by Application
    • 1.4.1 Overview: Global Molecular Point of Care (POC) Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Clinical
    • 1.4.3 Research
  • 1.5 Global Molecular Point of Care (POC) Market Size & Forecast
  • 1.6 Global Molecular Point of Care (POC) Market Size and Forecast by Region
    • 1.6.1 Global Molecular Point of Care (POC) Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Molecular Point of Care (POC) Market Size by Region, (2018-2029)
    • 1.6.3 North America Molecular Point of Care (POC) Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Molecular Point of Care (POC) Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Molecular Point of Care (POC) Market Size and Prospect (2018-2029)
    • 1.6.6 South America Molecular Point of Care (POC) Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Molecular Point of Care (POC) Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Molecular Point of Care (POC) Product and Solutions
    • 2.1.4 Abbott Laboratories Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Aidian Oy
    • 2.2.1 Aidian Oy Details
    • 2.2.2 Aidian Oy Major Business
    • 2.2.3 Aidian Oy Molecular Point of Care (POC) Product and Solutions
    • 2.2.4 Aidian Oy Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Aidian Oy Recent Developments and Future Plans
  • 2.3 Akonni Biosystems
    • 2.3.1 Akonni Biosystems Details
    • 2.3.2 Akonni Biosystems Major Business
    • 2.3.3 Akonni Biosystems Molecular Point of Care (POC) Product and Solutions
    • 2.3.4 Akonni Biosystems Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Akonni Biosystems Recent Developments and Future Plans
  • 2.4 binx health, inc.
    • 2.4.1 binx health, inc. Details
    • 2.4.2 binx health, inc. Major Business
    • 2.4.3 binx health, inc. Molecular Point of Care (POC) Product and Solutions
    • 2.4.4 binx health, inc. Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 binx health, inc. Recent Developments and Future Plans
  • 2.5 Biocartis NV
    • 2.5.1 Biocartis NV Details
    • 2.5.2 Biocartis NV Major Business
    • 2.5.3 Biocartis NV Molecular Point of Care (POC) Product and Solutions
    • 2.5.4 Biocartis NV Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Biocartis NV Recent Developments and Future Plans
  • 2.6 bioMérieux SA
    • 2.6.1 bioMérieux SA Details
    • 2.6.2 bioMérieux SA Major Business
    • 2.6.3 bioMérieux SA Molecular Point of Care (POC) Product and Solutions
    • 2.6.4 bioMérieux SA Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 bioMérieux SA Recent Developments and Future Plans
  • 2.7 Cepheid
    • 2.7.1 Cepheid Details
    • 2.7.2 Cepheid Major Business
    • 2.7.3 Cepheid Molecular Point of Care (POC) Product and Solutions
    • 2.7.4 Cepheid Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cepheid Recent Developments and Future Plans
  • 2.8 Credo Bioscience
    • 2.8.1 Credo Bioscience Details
    • 2.8.2 Credo Bioscience Major Business
    • 2.8.3 Credo Bioscience Molecular Point of Care (POC) Product and Solutions
    • 2.8.4 Credo Bioscience Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Credo Bioscience Recent Developments and Future Plans
  • 2.9 Curetis NV
    • 2.9.1 Curetis NV Details
    • 2.9.2 Curetis NV Major Business
    • 2.9.3 Curetis NV Molecular Point of Care (POC) Product and Solutions
    • 2.9.4 Curetis NV Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Curetis NV Recent Developments and Future Plans
  • 2.10 DiaSorin S.p.A
    • 2.10.1 DiaSorin S.p.A Details
    • 2.10.2 DiaSorin S.p.A Major Business
    • 2.10.3 DiaSorin S.p.A Molecular Point of Care (POC) Product and Solutions
    • 2.10.4 DiaSorin S.p.A Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 DiaSorin S.p.A Recent Developments and Future Plans
  • 2.11 GenMark Diagnostics
    • 2.11.1 GenMark Diagnostics Details
    • 2.11.2 GenMark Diagnostics Major Business
    • 2.11.3 GenMark Diagnostics Molecular Point of Care (POC) Product and Solutions
    • 2.11.4 GenMark Diagnostics Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 GenMark Diagnostics Recent Developments and Future Plans
  • 2.12 Greiner Bio-One GmbH
    • 2.12.1 Greiner Bio-One GmbH Details
    • 2.12.2 Greiner Bio-One GmbH Major Business
    • 2.12.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Product and Solutions
    • 2.12.4 Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Greiner Bio-One GmbH Recent Developments and Future Plans
  • 2.13 Meridian Bioscience, Inc.
    • 2.13.1 Meridian Bioscience, Inc. Details
    • 2.13.2 Meridian Bioscience, Inc. Major Business
    • 2.13.3 Meridian Bioscience, Inc. Molecular Point of Care (POC) Product and Solutions
    • 2.13.4 Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
  • 2.14 Mesa Biotech, Inc.
    • 2.14.1 Mesa Biotech, Inc. Details
    • 2.14.2 Mesa Biotech, Inc. Major Business
    • 2.14.3 Mesa Biotech, Inc. Molecular Point of Care (POC) Product and Solutions
    • 2.14.4 Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Mesa Biotech, Inc. Recent Developments and Future Plans
  • 2.15 QIAGEN NV
    • 2.15.1 QIAGEN NV Details
    • 2.15.2 QIAGEN NV Major Business
    • 2.15.3 QIAGEN NV Molecular Point of Care (POC) Product and Solutions
    • 2.15.4 QIAGEN NV Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 QIAGEN NV Recent Developments and Future Plans
  • 2.16 QuantuMDx Group
    • 2.16.1 QuantuMDx Group Details
    • 2.16.2 QuantuMDx Group Major Business
    • 2.16.3 QuantuMDx Group Molecular Point of Care (POC) Product and Solutions
    • 2.16.4 QuantuMDx Group Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 QuantuMDx Group Recent Developments and Future Plans
  • 2.17 Quidel Corporation
    • 2.17.1 Quidel Corporation Details
    • 2.17.2 Quidel Corporation Major Business
    • 2.17.3 Quidel Corporation Molecular Point of Care (POC) Product and Solutions
    • 2.17.4 Quidel Corporation Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Quidel Corporation Recent Developments and Future Plans
  • 2.18 Roche
    • 2.18.1 Roche Details
    • 2.18.2 Roche Major Business
    • 2.18.3 Roche Molecular Point of Care (POC) Product and Solutions
    • 2.18.4 Roche Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Roche Recent Developments and Future Plans
  • 2.19 Sekisui Diagnostics LLC
    • 2.19.1 Sekisui Diagnostics LLC Details
    • 2.19.2 Sekisui Diagnostics LLC Major Business
    • 2.19.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Product and Solutions
    • 2.19.4 Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Sekisui Diagnostics LLC Recent Developments and Future Plans
  • 2.20 T2 Biosystems
    • 2.20.1 T2 Biosystems Details
    • 2.20.2 T2 Biosystems Major Business
    • 2.20.3 T2 Biosystems Molecular Point of Care (POC) Product and Solutions
    • 2.20.4 T2 Biosystems Molecular Point of Care (POC) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 T2 Biosystems Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Molecular Point of Care (POC) Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Molecular Point of Care (POC) by Company Revenue
    • 3.2.2 Top 3 Molecular Point of Care (POC) Players Market Share in 2022
    • 3.2.3 Top 6 Molecular Point of Care (POC) Players Market Share in 2022
  • 3.3 Molecular Point of Care (POC) Market: Overall Company Footprint Analysis
    • 3.3.1 Molecular Point of Care (POC) Market: Region Footprint
    • 3.3.2 Molecular Point of Care (POC) Market: Company Product Type Footprint
    • 3.3.3 Molecular Point of Care (POC) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Molecular Point of Care (POC) Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Molecular Point of Care (POC) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Molecular Point of Care (POC) Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Molecular Point of Care (POC) Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Molecular Point of Care (POC) Consumption Value by Type (2018-2029)
  • 6.2 North America Molecular Point of Care (POC) Consumption Value by Application (2018-2029)
  • 6.3 North America Molecular Point of Care (POC) Market Size by Country
    • 6.3.1 North America Molecular Point of Care (POC) Consumption Value by Country (2018-2029)
    • 6.3.2 United States Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Molecular Point of Care (POC) Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Molecular Point of Care (POC) Consumption Value by Type (2018-2029)
  • 7.2 Europe Molecular Point of Care (POC) Consumption Value by Application (2018-2029)
  • 7.3 Europe Molecular Point of Care (POC) Market Size by Country
    • 7.3.1 Europe Molecular Point of Care (POC) Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 7.3.3 France Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Molecular Point of Care (POC) Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Molecular Point of Care (POC) Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Molecular Point of Care (POC) Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Molecular Point of Care (POC) Market Size by Region
    • 8.3.1 Asia-Pacific Molecular Point of Care (POC) Consumption Value by Region (2018-2029)
    • 8.3.2 China Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 8.3.5 India Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Molecular Point of Care (POC) Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Molecular Point of Care (POC) Consumption Value by Type (2018-2029)
  • 9.2 South America Molecular Point of Care (POC) Consumption Value by Application (2018-2029)
  • 9.3 South America Molecular Point of Care (POC) Market Size by Country
    • 9.3.1 South America Molecular Point of Care (POC) Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Molecular Point of Care (POC) Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Molecular Point of Care (POC) Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Molecular Point of Care (POC) Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Molecular Point of Care (POC) Market Size by Country
    • 10.3.1 Middle East & Africa Molecular Point of Care (POC) Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Molecular Point of Care (POC) Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Molecular Point of Care (POC) Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Molecular Point of Care (POC) Market Drivers
  • 11.2 Molecular Point of Care (POC) Market Restraints
  • 11.3 Molecular Point of Care (POC) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Molecular Point of Care (POC) Industry Chain
  • 12.2 Molecular Point of Care (POC) Upstream Analysis
  • 12.3 Molecular Point of Care (POC) Midstream Analysis
  • 12.4 Molecular Point of Care (POC) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Molecular Point of Care (POC). Industry analysis & Market Report on Molecular Point of Care (POC) is a syndicated market report, published as Global Molecular Point of Care (POC) Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Molecular Point of Care (POC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,756.16
    4,134.24
    5,512.32
    3,222.48
    4,833.72
    6,444.96
    526,698.00
    790,047.00
    1,053,396.00
    290,232.00
    435,348.00
    580,464.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report